company background image
GTHX logo

G1 Therapeutics NasdaqGS:GTHX Stok Raporu

Son Fiyat

US$7.15

Piyasa Değeri

US$378.2m

7D

0.3%

1Y

433.6%

Güncellenmiş

18 Sep, 2024

Veri

Şirket Finansalları +

G1 Therapeutics, Inc.

NasdaqGS:GTHX Stok Raporu

Piyasa değeri: US$378.2m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

GTHX Stoklara Genel Bakış

A commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer in the United States.

G1 Therapeutics, Inc. Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti G1 Therapeutics
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$7.15
52 Haftanın En Yüksek SeviyesiUS$7.19
52 Haftanın En Düşük SeviyesiUS$1.08
Beta1.68
11 Aylık Değişim0.85%
3 Aylık Değişim182.61%
1 Yıllık Değişim433.58%
33 Yıllık Değişim-52.55%
5 Yıllık Değişim-78.80%
Halka arzdan bu yana değişim-52.33%

Son Haberler & Güncellemeler

Recent updates

There's No Escaping G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Muted Revenues Despite A 80% Share Price Rise

Jul 26
There's No Escaping G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Muted Revenues Despite A 80% Share Price Rise

G1 Therapeutics: Failure Of Breast Cancer Underscores Long-Term Uncertainty

Jun 24

Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why

Jun 07
Shareholders May Not Be So Generous With G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Compensation And Here's Why

Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

May 28
Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why G1 Therapeutics Is A Speculative 'Buy' In The Oncology Biotech Landscape

Mar 22

Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge

Feb 27
Why Investors Shouldn't Be Surprised By G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 44% Share Price Plunge

Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?

Feb 06
Does G1 Therapeutics (NASDAQ:GTHX) Have A Healthy Balance Sheet?

G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry

Jan 04
G1 Therapeutics, Inc. (NASDAQ:GTHX) Stock Catapults 61% Though Its Price And Business Still Lag The Industry

Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

Jun 08
Little Excitement Around G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Revenues

New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)

May 08
New Forecasts: Here's What Analysts Think The Future Holds For G1 Therapeutics, Inc. (NASDAQ:GTHX)

The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts

Nov 04
The G1 Therapeutics, Inc. (NASDAQ:GTHX) Analysts Have Been Trimming Their Sales Forecasts

G1 Therapeutics: Catalysts Stacking

Oct 20

G1 Therapeutics: Building A Franchise

Sep 29

Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)

Aug 04
Analysts Just Published A Bright New Outlook For G1 Therapeutics, Inc.'s (NASDAQ:GTHX)

G1 Therapeutics Q2 2022 Earnings Preview

Aug 02

G1 Therapeutics: Take Advantage Of The November Data

Jul 22

Hissedar Getirileri

GTHXUS BiotechsUS Pazar
7D0.3%3.7%5.7%
1Y433.6%29.2%36.9%

Getiri vs. Endüstri: GTHX geçen yıl % 29.2 oranında getiri sağlayan US Biotechs sektörünü aştı.

Getiri vs Piyasa: GTHX geçen yıl % 36.9 oranında getiri sağlayan US Piyasasını aştı.

Fiyat Oynaklığı

Is GTHX's price volatile compared to industry and market?
GTHX volatility
GTHX Average Weekly Movement19.9%
Biotechs Industry Average Movement9.5%
Market Average Movement6.2%
10% most volatile stocks in US Market15.3%
10% least volatile stocks in US Market3.0%

İstikrarlı Hisse Senedi Fiyatı: GTHX hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: GTHX 'nin haftalık oynaklığı ( 20% ) geçen yıl boyunca sabit kaldı, ancak hala US hisselerinin %75'inden yüksek.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
2008100Jack Baileywww.g1therapeutics.com

G1 Therapeutics, Inc. Temel Bilgiler Özeti

G1 Therapeutics'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
GTHX temel i̇stati̇sti̇kler
Piyasa değeriUS$378.17m
Kazançlar(TTM)-US$44.77m
Gelir(TTM)US$58.20m

6.5x

P/S Oranı

-8.4x

F/K Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
GTHX gelir tablosu (TTM)
GelirUS$58.20m
Gelir MaliyetiUS$6.14m
Brüt KârUS$52.05m
Diğer GiderlerUS$96.82m
Kazançlar-US$44.77m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-0.85
Brüt Marj89.44%
Net Kâr Marjı-76.93%
Borç/Özkaynak Oranı180.2%

GTHX uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün